Dr. Keith Nuechterlein, a distinguished professor of psychiatry and biobehavioral sciences and of psychology at UCLA, has received the 2019 Outstanding Clinical/Community Research Award from the Schizophrenia International Research Society.

The society, which facilitates international collaboration to discover the causes of and better treatments for schizophrenia, presented Nuechterlein with the award at its annual International Congress in Orlando, Florida. The society presents the award annually in recognition of a scientists’ outstanding contributions to the advancement of schizophrenia research.

Nuechterlein, who also is director of the Aftercare Program, a research clinic for patients with schizophrenia at UCLA’s Jane and Terry Semel Institute for Neuroscience and Human Behavior, focuses his research on treatments and interventions for schizophrenia, with an emphasis on improving cognition in newly diagnosed patients.

He has authored more than 300 articles and has been named to a list of the most highly cited and influential scientists in the world. Nuechterlein assisted in the development of the MATRICS Consensus Cognitive Battery, considered to be the gold standard outcome measure for clinical trials to assess the impact of new interventions on core cognitive deficits in schizophrenia.